m f ahmad , t ramalingam , m a abu , n h abd aziz , a k abdul karim , n abd shukor , m n shafiee.  (2025).  effects of co-treatment of gnrh-analog alone or in combination with aromatase inhibitor or progestin on endometrial apha-beta-3 integrin expressions in women with recurrent miscarriage.  - human reproduction.  401 - 402. 

abdul muzhill hannaan abdul hafizz, norfilza mohd mokthar, reena rahayu md zin, nigel p. mongan, mohd nazzary mamat @ yusof, nirmala chandralega kampan, kah teik chew and mohamad nasir shafiee .  (2025).  insulin-like growth factor 1 (igf1) and its isoforms: insights into the mechanisms of endometrial cancer.  - cancers.  1 - 19. 

abdul muzhill hannaan abdul hafizz, norfilza mohd mokthar, reena rahayu md zin, nigel p. mongan, mohd nazzary mamat @ yusof, nirmala chandralega kampan, kah teik chew and mohamad nasir shafiee .  (2025).  insulin-like growth factor 1 (igf1) and its isoforms: insights into the mechanisms of endometrial cancer.  - cancers.  1 - 19. 

beibei zhang, nur fatin nabilah mohd sahardi, kah teik chew, wen di and mohamad nasir shafiee.  (2025).  gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review.  - frontiers in oncology.  1 - 15. 

madhuri s. salker, nor haslinda abd aziz, natalia carman prodan, zhiqi yang, aditya kumar lankapalli, katrin lazar, mohamad nasir shafiee, ersoy kocak, harivignesh ganesa, surya sekhar pal, omer khalid, norhana mohd kasim, aida kalok, norashikin abdul fuad, alfred lennart bissinger, tina ganzenmueller, thomas iftner, karl oliver kagan, stephan ossowski, sara y. brucker, olaf riess, and for deutsche covid-19 omics.  (2025).  single-cell rna-sequencing highlights a curtailed nk cell function in convalescent covid-19 pregnant women.  - frontiers in immunology .  1 - 28. 

nur fatin nabilah mohd sahardi, manishaa priya, suzana makpol, mohamad nasir shafiee.  (2025).  clinical translation of metabolomics markers in endometrial carcinoma.  - journal of obstetrics and gynecology research.  1 - 11. 

naim syahidah zulkafli, suria hayati md pauzi, asmazila baharum, mohamad nasir shafiee, mohd rizal abdul manaf, sharifah noor akmal s.h. shahabudin, nurismah md isa.  (2021).  high risk-hpv dna test and association with cyto-histopathological finding of cervical neoplasia: an audit study.  - malaysian journal of pathology.  466. 

mohamad nasir shafiee,nurlina razak,mohd faizal ahmad, norhaslinda abd aziz & nafisah adeeb.  (2021).  a single centre experience of metabolic syndrome and endometrial carcinoma: 5 years review.  - journal of obstetrics and gynaecology.  285-289. 

n kampan, j silva raju, kt chew, mf mohd saleh, rr md zin, r jeganathan, mn shafieeand n abd aziz.  (2020).  the protein expression of tnfr2 and stat3 in high-grade serous ovarian cancer (hgsc) tissue and its association with platinum sensitivity.  - international journal of gynecological cancer.  A47. 

chew kah teik, nirmala kampan, mohamad nasir shafiee.  (2020).  recurrence of ovarian cancer with distant metastasis after five years: a single institute experience.  - international journal of gynecological cancer.  A74-A75. 

beibei zhang, nur fatin nabilah mohd sahardi, wen di, xiaoran ling and mohamad nasir shafiee.  (2025).  the gut–endometrium axis: exploring the role of microbiome in the pathogenesis and treatment of endometrial cancer—a narrative review.  - cancers.  1 - 19. 

mohd nazzary mamat @ yusof, kah teik chew , nirmala chandralega kampan, abdul muzhill hannaan abdul hafizz, mohamad nasir shafiee .  (2025).  gene expression and soluble protein level of pd-1 and its ligands (pd-l1 and pd-l2) in endometrial cancer.  - plos one.  1 - 15. 

m f ahmad , t ramalingam , m a abu , n h abd aziz , a k abdul karim , n abd shukor , m n shafiee.  (2025).  effects of co-treatment of gnrh-analog alone or in combination with aromatase inhibitor or progestin on endometrial apha-beta-3 integrin expressions in women with recurrent miscarriage.  - human reproduction.  401 - 402. 

beibei zhang, nur fatin nabilah mohd sahardi, kah teik chew, wen di and mohamad nasir shafiee.  (2025).  gut microbiome alterations and their clinical and biological implications in ovarian cancer: a systematic review.  - frontiers in oncology.  1 - 15. 

nur fatin nabilah mohd sahardi, manishaa priya, suzana makpol, mohamad nasir shafiee.  (2025).  clinical translation of metabolomics markers in endometrial carcinoma.  - journal of obstetrics and gynecology research.  1 - 11. 

ahmad mohd faizal, abd aziz nor haslinda, mohd saleh muhamad fakhri, shafiee mohamad nasir, abd shukor nordashima, abu muhammad azrai, abdul karim abdul kadir.  (2023).  effects of co-treatment of gnrh-analog alone or in combination with aromatase inhibitor or progestin on endometrial a?ß3 integrin expressions in women with recurrent miscarriage.  - medical journal of malaysia.  5 - 5. 

nirmala chandralega kampan, chew kah teik, mohamed nasir shafiee, abdul kadir abdul karim, lim pei shan, nor azlin mohamed ismail, nur azurah abd ghani.  (2022).  obstetrics and gynaecology postgraduate programme during the covid-19 pandemic (2020-2021): the challenges of transitioning from face-to-face to online teaching-learning platform.  - .  251-259. 

mohammad nasir shafiee, nirmala kampan, rahaya bustamam.  (2019).  admission policy and risk management.  - .  1-234. 

aida hani mohd kalok, lim pei shan, mohd hashim omar, mohamad nasir shafiee, ng beng kwang.  (2019).  third stage of labour.  - .  142-158. 

lim pei shan, ng beng kwang, nur azurah abd ghani, mohd nasir shafiee.  (2016).  laparoscopic chromotubation.  - .  75-77. 

mohd nasir shafiee, yuen yee wei, abdul kadir, nur azurah abd ghani.  (2016).  safe port entry.  - .  41-46. 

abu bakar sulong, norfilza mohd mokhtar, mohamad nasir sahfiee, yap wei boon, caryn chan mei hsein, mohd kaisan mahadi, mohamad aimanuddin mohtar.  (2022).  impak: kluster kesihatan & perubatan termaju.  - impak: kluster kesihatan & perubatan termaju.  1-44. 

yulianty arifuddin, chew kah teik, mohamad nasir shafiee.  (2017).  (human papilloma virus) vaksin dan kanser serviks: adakah saya terlewat?.  - impak penyelidikan translasi@ukm.  9-10. 

dr mohamad nasir shafiee.  (2012).  dari fail doktor rtm.  - hamil songsang risiko kematian bayi.  . 

dr mohamad nasir shafiee.  (2011).  dokumentari: sengugut.  - dari fail doktor rtm.  . 

dr mohamad nasir shafiee.  (2011).  dari fail doktor rtm musim 2.  - ivf.  . 

anizah ali, nur aisyah suhaimi, maryam `awatif yahya, izyan atiqah zakaria, nurul ilani abdul latif, mohd. nasir shafiee, ixora kamisan atan.  (2025).  a common drug, an uncommon reaction: misoprostol-induced seizure: case insight and literature perspectives.  - 32nd international congress of the obstetrical and gynaecological society of malaysia (ogsm).  1 - 1. 

vikneswary ravi kumar, nirmala chandralega kampan, chew kah teik, mohamad nasir shafiee and p. susthitha menon.  (2025).  unravelling the potential utility of three serum biomarkers (ca125, he4 and ccll11) in distinguishing between benign and malignant epithelial ovarian cancer (eoc).  - 6th endometriosis research scientific expert and well women congress.  . 

nirmala @ chandralega a/p kampan;mohamad nasir bin shafiee;nor haslinda binti abd aziz;p. susthitha menon a/p n v visvanathan;chew kah teik.  (2024).  developing a multi-biomarker signature panel for diagnosis of epithelial ovarian cancer using surface plasmon resonance (spr) technology and validation with multiplex immunobead assay and single cell sequencing..  - .  . 

mohamad nasir shafiee, abdul muzhill hannaan abdul hafizz, reena rahayu md zin, muaatamarulain mustangin, nirmala chandralega kampan, chew kah teik, norfilza mohd mokthar.  (2024).  igf1 and pten expressions prognosticate outcomes in endometrioid endometrial cancer (eec).  - the 8th biennial meeting of the asian society of gynecologic oncology (asgo 2023).  126 - 126. 

nirmala @ chandralega a/p kampan;mohd hashim bin omar;norfilza mohd mokhtar;mohamad nasir bin shafiee;nor haslinda binti abd aziz;chew kah teik;reena rahayu md zin.  (2023).  detection of inflammatory and immunosuppressive molecular alteration signatures to prevent disease relapse in women with high-grade serous ovarian cancer. .  - .  .